Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Financials
52W LOW $140.0852W HIGH $246.32
Volume
450.80 K
Value Traded
126.42 M
Short % Float
5.24%
Days to Cover
2.8
+2.52%Week
+5.59%1 Month
+17.31%3 Month
+4.11%6 Month
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Market Cap
11.01 B
EPS (TTM)
25.89
P/E Ratio
7.22
Ent. Value
16.55 B
Total Shares
58.94 M
Float Shares
48.79 M
Insiders
17.21%
Institutions
93.46%
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | Small Molecule | Oncology | - |
PoA blends historical approval base rates, trial design score and FDA review track record.
UHS Catalyst Timeline
Dated clinical, regulatory and corporate events for Universal Health Services, Inc. Class B
Past FDA Catalysts and PDUFA Decisions
How UHS actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| - | Example Drug | Phase 3 data readout | Phase 3 |
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision
Drug Pipeline Intelligence
No drug pipeline
Universal Health Services, Inc. Class B is a services and tools company (CRO, lab tools or healthcare services). The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every UHS program
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| MILLER ALAN BDirector, Officer (Executive Chairman), 10% Owner | Other | -13,963 | $0.00 | 05/27/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in UHS
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| PFM HEALTH SCIENCES, LP | 1.2 % (-33.3 %) | 12.52 M | 57.41 K | -50.62% ( -58.85 K) |
UHS Institutional Ownership Trends
UHS Short Interest
Shares sold short, counted twice a month.
5.24%
Short % of Float
of tradable shares sold short
2.6M
Shares Sold Short
-6.0% vs prior count
2.8 Moderate
Days to Cover
trading days of normal volume to buy every short share back
900.0K
Avg Daily Volume
the average used for days to cover
Options Data
Option Volume
Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | ||||||||||||
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
CallsPutsLog scale
Competitive positioning
How UHS ranks across every disease it competes in
Competitive Position is a premium feature
See how UHS ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trialUHS News
-UHS
Oct 9, 2026Universal Health Services, Inc. Announces Date and Time Change for Third Quarter 2026 Earnings Release and Conference Call
Universal Health Services, Inc. will report its third-quarter results on October 27, 2026, after market close. The conference call for investors is now set for 8:00 a.m. ET on October 28, 2026. This change aims to prevent scheduling conflicts with other healthcare companies' calls.
Read more →-UHS
Oct 5, 2026Universal Health Services, Inc. Announces Date for Third Quarter 2026 Earnings Release and Conference Call
Universal Health Services, Inc. will announce its third quarter results on October 26, 2026, after market close. A conference call for investors is scheduled for October 27, 2026, at 9:30 a.m. Eastern Time. The call will be accessible via a live webcast and telephone registration.
Read more →-UHS
Aug 25, 2026UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT SEPTEMBER HEALTHCARE CONFERENCES
Universal Health Services, Inc. (UHS) will present at several upcoming healthcare conferences in September 2026. The presentations are scheduled for September 8, 14, and 15, where UHS will showcase its services and achievements. A live audio webcast will be available for those interested in the presentations.
Read more →-UHS
Aug 17, 2026Universal Health Services, Inc. Completes Acquisition of Talkspace, Inc.
Universal Health Services completed its acquisition of Talkspace on August 17, 2026. The deal combines UHS physical facilities with Talkspace’s virtual platform to create a full continuum of behavioral healthcare. Talkspace serves over 200 million people through more than 200 insurance plans and employer programs. This integration aims to improve care coordination across virtual and inpatient settings.
Read more →-UHS
Jul 27, 2026UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND SIX-MONTH PERIODS ENDED JUNE 30, 2026, AND REVISES 2026 FULL YEAR OPERATING RESULTS FORECAST
Universal Health Services, Inc. (UHS) reported a net income of $358.4 million for Q2 2026, reflecting an increase from $353.2 million in Q2 2025. The company also saw an 8.3% rise in net revenues to $4.638 billion during the same period. However, UHS revised its 2026 full-year operating results forecast, indicating a potential decrease in adjusted EBITDA compared to earlier projections. The company continues to invest in its facilities and services to enhance patient care.
Read more →-UHS
Jul 15, 2026UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DIVIDEND
Universal Health Services, Inc. has declared a cash dividend of $0.20 per share, payable on September 15, 2026, to shareholders on record as of September 1, 2026. This announcement reflects the company's ongoing commitment to rewarding its investors. UHS is recognized as a leading provider of healthcare services across the U.S., Puerto Rico, and the UK.
Read more →-UHS
Jul 6, 2026UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DATE FOR SECOND QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALL
Universal Health Services, Inc. has announced the date for its second quarter 2026 earnings release, set for July 27, 2026. A conference call for investors will follow on July 28, 2026, at 9:00 a.m. ET. The company emphasizes its commitment to investor relations through live webcasts and detailed participation instructions.
Read more →-UHS
May 27, 2026UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT GOLDMAN SACHS ANNUAL GLOBAL HEALTHCARE CONFERENCE
Universal Health Services, Inc. is set to present at the Goldman Sachs Annual Global Healthcare Conference on June 9, 2026. The presentation will be accessible via a live audio webcast, highlighting the company's role as a leading provider of healthcare services across the U.S., U.K., and Puerto Rico. This event underscores UHS's commitment to investor engagement.
Read more →-UHS
Apr 30, 2026UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT BOFA SECURITIES HEALTH CARE CONFERENCE
Universal Health Services, Inc. will present at the BofA Securities Health Care Conference on May 12, 2026, at 1:40 PM PT. A live audio webcast of the presentation will be accessible on the company's Investor Relations website. The company is a prominent provider of hospital and healthcare services across the U.S., U.K., and Puerto Rico.
Read more →-UHS
Apr 27, 2026UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE-MONTH PERIOD ENDED MARCH 31, 2026
Universal Health Services, Inc. reported strong financial results for the first quarter of 2026, with net income rising to $348.7 million, up from $316.7 million in the same period last year. The company experienced a 9.6% increase in net revenues, totaling $4.495 billion. Adjusted EBITDA also saw growth, reaching $648.3 million. However, rising operating expenses and interest costs present challenges for future profitability.
Read more →-UHS
Mar 9, 2026Universal Health Services, Inc. to Acquire Talkspace, Inc.
Universal Health Services (UHS) has entered a definitive agreement to acquire Talkspace for $5.25 per share, totaling an enterprise value of approximately $835 million. This acquisition is expected to enhance UHS's outpatient and telehealth behavioral health strategies, providing greater access to mental healthcare services. The deal, which has received approval from both boards of directors, will close in Q3 2026, pending stockholder and regulatory approvals. UHS anticipates this merger to be accretive to its net income in the first year post-closing.
Read more →-UHS
Dec 7, 2022SEPARATION AGREEMENT AND GENERAL RELEASE UHS of Delaware, Inc. ("UHS" or "Employer") and Marvin Pember ("Employee") (together, "Parties") enter into this Separation Agreement and General Release ("Agreement") effective a
SEPARATION AGREEMENT AND GENERAL RELEASE UHS of Delaware, Inc. ("UHS" or "Employer") and Marvin Pember ("Employee") (together, "Parties") enter into this Separation Agreement and General Release ("Agreement") effective as of December 31, 2022 ("Effective Date"). WHEREAS, UHS an
Read more →-UHS
Jul 10, 2020Steve Filton Chief Financial Officer
CONTACT:Steve Filton Chief Financial OfficerJuly 10, 2020 UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES FINAL SETTLEMENT RESOLVING THE GOVERNMENT'S INVESTIGATION OF OUR BEHAVIORAL HEALTH CARE FACILITIES KING OF PRUSSIA, PA - Universal Health Services, Inc. (NYSE: UHS; the "Compan
Read more →-UHS
Dec 6, 2018Universal Health Services, Inc. Announces Retirement of Debra K. Osteen, President of the Behavioral Health Division 12/6/2018
Universal Health Services, Inc. Announces Retirement of Debra K. Osteen, President of the Behavioral Health Division KING OF PRUSSIA, Pa., December 6, 2018 Universal Health Services, Inc. (NYSE: UHS) today announced that Debra K. Osteen, President of the Behavioral Health Divis
Read more →-UHS
Dec 8, 2016Steve Filton
CONTACT: Steve Filton December 8, 2016 Chief Financial Officer 610-768-3300 UNIVERSAL HEALTH SERVICES, INC. STATEMENT REGARDING RECENT BUZZFEED ARTICLE KING OF PRUSSIA, PA- Universal Health Services, Inc. (NYSE:UHS) issued the following statement today in respo
Read more →About Universal Health Services, Inc. Class B
Headquarters367 S GULPH RD, KING OF PRUSSIA, PA, 19406
BIOPHARMAWATCH ELITE PLUS
Trade the next UHS catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime